Barclays’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99K | Sell |
7,519
-30,655
| -80% | -$404K | ﹤0.01% | 3818 |
|
|
2025
Q1 | $549K | Buy |
38,174
+32,872
| +620% | +$473K | ﹤0.01% | 2792 |
|
|
2024
Q4 | $89K | Buy |
5,302
+4,952
| +1,415% | +$83.1K | ﹤0.01% | 3820 |
|
|
2024
Q3 | $6K | Buy |
+350
| New | +$6K | ﹤0.01% | 4174 |
|
|
2024
Q1 | – | Sell |
-6,400
| Closed | -$51K | – | 4173 |
|
|
2023
Q4 | $51K | Hold |
6,400
| – | – | ﹤0.01% | 3843 |
|
|
2023
Q3 | $41K | Hold |
6,400
| – | – | ﹤0.01% | 3674 |
|
|
2023
Q2 | $40K | Hold |
6,400
| – | – | ﹤0.01% | 3763 |
|
|
2023
Q1 | $25K | Buy |
+6,400
| New | +$25K | ﹤0.01% | 3951 |
|